Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 28% ± 10% | |
endothelial cell | 4 studies | 20% ± 4% | |
glutamatergic neuron | 4 studies | 30% ± 10% | |
GABAergic neuron | 3 studies | 26% ± 6% | |
astrocyte | 3 studies | 20% ± 4% | |
dendritic cell | 3 studies | 27% ± 15% | |
abnormal cell | 3 studies | 18% ± 2% | |
transit amplifying cell | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3161.57 | 21 / 21 | 100% | 30.40 | 504 / 504 |
breast | 100% | 3657.51 | 459 / 459 | 100% | 30.80 | 1118 / 1118 |
esophagus | 100% | 2733.48 | 1445 / 1445 | 100% | 29.25 | 183 / 183 |
intestine | 100% | 3314.79 | 966 / 966 | 100% | 30.05 | 527 / 527 |
lung | 100% | 2839.03 | 578 / 578 | 100% | 26.32 | 1155 / 1155 |
ovary | 100% | 3332.07 | 180 / 180 | 100% | 25.43 | 430 / 430 |
pancreas | 100% | 1830.23 | 328 / 328 | 100% | 27.38 | 178 / 178 |
prostate | 100% | 3315.18 | 245 / 245 | 100% | 27.29 | 502 / 502 |
skin | 100% | 3333.82 | 1809 / 1809 | 100% | 29.42 | 472 / 472 |
stomach | 100% | 2371.20 | 359 / 359 | 100% | 28.08 | 286 / 286 |
uterus | 100% | 3725.22 | 170 / 170 | 100% | 31.99 | 459 / 459 |
thymus | 100% | 3213.86 | 653 / 653 | 100% | 26.99 | 603 / 605 |
kidney | 100% | 2410.82 | 89 / 89 | 99% | 30.21 | 896 / 901 |
liver | 100% | 1829.12 | 226 / 226 | 99% | 15.82 | 403 / 406 |
adrenal gland | 100% | 2787.41 | 258 / 258 | 99% | 20.66 | 228 / 230 |
brain | 98% | 1582.65 | 2602 / 2642 | 100% | 27.63 | 705 / 705 |
adipose | 100% | 3460.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2805.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.61 | 29 / 29 |
muscle | 100% | 2842.98 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4273.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.42 | 1 / 1 |
heart | 99% | 1661.50 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 19.17 | 78 / 80 |
peripheral blood | 93% | 1595.16 | 867 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0007076 | Biological process | mitotic chromosome condensation |
GO_0015031 | Biological process | protein transport |
GO_0044839 | Biological process | cell cycle G2/M phase transition |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0001939 | Cellular component | female pronucleus |
GO_0005730 | Cellular component | nucleolus |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0000793 | Cellular component | condensed chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0034237 | Molecular function | protein kinase A regulatory subunit binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0051059 | Molecular function | NF-kappaB binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | AKAP8 |
Protein name | A-kinase anchoring protein 8 A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95) AKAP8 protein |
Synonyms | AKAP95 |
Description | FUNCTION: Anchoring protein that mediates the subcellular compartmentation of cAMP-dependent protein kinase (PKA type II) . Acts as an anchor for a PKA-signaling complex onto mitotic chromosomes, which is required for maintenance of chromosomes in a condensed form throughout mitosis. Recruits condensin complex subunit NCAPD2 to chromosomes required for chromatin condensation; the function appears to be independent from PKA-anchoring . May help to deliver cyclin D/E to CDK4 to facilitate cell cycle progression . Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function may act redundantly with AKAP8L . Involved in nuclear retention of RPS6KA1 upon ERK activation thus inducing cell proliferation . May be involved in regulation of DNA replication by acting as scaffold for MCM2 . Enhances HMT activity of the KMT2 family MLL4/WBP7 complex and is involved in transcriptional regulation. In a teratocarcinoma cell line is involved in retinoic acid-mediated induction of developmental genes implicating H3 'Lys-4' methylation . May be involved in recruitment of active CASP3 to the nucleus in apoptotic cells . May act as a carrier protein of GJA1 for its transport to the nucleus . May play a repressive role in the regulation of rDNA transcription. Preferentially binds GC-rich DNA in vitro. In cells, associates with ribosomal RNA (rRNA) chromatin, preferentially with rRNA promoter and transcribed regions . Involved in modulation of Toll-like receptor signaling. Required for the cAMP-dependent suppression of TNF-alpha in early stages of LPS-induced macrophage activation; the function probably implicates targeting of PKA to NFKB1 (By similarity). . |
Accessions | ENST00000680245.1 O43823 ENST00000681812.1 A0A7P0TBC8 ENST00000598597.7 Q8NE02 ENST00000269701.7 ENST00000599883.2 ENST00000680461.1 M0QX51 A0A7P0TAA4 A0A7P0T893 |